Iambic Therapeutics jumps 16% in Nasdaq debut after $150M IPO
Posted On October 15, 2026
Iambic’s successful IPO highlights growing investor confidence in AI-driven biotech, potentially accelerating innovation in cancer treatment.
The post Iambic Therapeutics jumps 16% in Nasdaq debut after $150M IPO appeared first on Crypto Briefing.
About The Author
